Abstract
This study is a retrospective analysis of clinico-pathological data to investigate survival rates of patients with oropharyngeal squamous cell carcinoma (OPSCC) treated with different modalities in a single academic head and neck cancer center in different time intervals. Altogether, 287 patients with OPSCC were included in this comparison. Patients were analysed during two different treatment periods: Group 1 included patients treated mainly with primary surgery ± adjuvant radio(chemo)therapy between 2002 and 2007, while Group 2 included patients treated with organ/function-preservation protocols if indicated. Main outcome measures were overall survival (OS) and recurrence-free survival (RFS). Between 2002 and 2007, early-stage OPSCC showed a 5-year OS of 75% compared to that of 86% between 2008 and 2013. Locally advanced OPSCC showed a 5-year OS of 66% between 2002 and 2007 compared to that of 74% between 2008 and 2013. RFS in early-stage OPSCC was 48% between 2002 and 2007 in contrast to that of 77% between 2008 and 2013. With locally advanced OPSCC, RFS was 55% between 2002 and 2007 compared to that of 56% between 2008 and 2013. These differences were statistically not significant. The OS and RFS remained generally unchanged over the analysed time period. There was no significant difference in the outcomes with regards to HPV status and to their treatment modality.
Similar content being viewed by others
References
Hunter KD, Parkinson EK, Harrison PR (2005) Profiling early head and neck cancer. Nat Rev Cancer 5:127–135
Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
Chaturvedi AK, Anderson WF, Lortet-Tieulent J et al (2013) Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 31:4550–4559
Rousseau A, Badoual C (2012) Head and neck: squamous cell carcinoma: an overview. Atlas Genet Cytogenet Oncol Haematol 16:145–155
Nguyen NP, Vos P, Smith HJ et al (2007) Concurrent chemoradiation for locally advanced oropharyngeal cancer. Am J Otolaryngol 28:3–8
Herrero R, Castellsague X, Pawlita M et al (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95:1772–1783
Fakhry C, Westra WH, Li S et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261–269
Bonilla-Velez J, Mroz EA, Hammon RJ et al (2013) Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment. Otolaryngol Clin N Am 46:521–543
Reeves TD, Hill EG, Armeson KE et al (2011) Cetuximab therapy for head and neck squamous cell carcinoma: a systematic review of the data. Otolaryngol Head Neck Surg 144:676–684
Munscher A, Sehner S, Taleh J et al (2014) Role of panendoscopy in identifying and managing risk of head and neck squamous cell carcinoma in routine follow-up: a retrospective clinical evaluation. Eur Arch Otorhinolaryngol 272(7):1769–1775
Volkenstein S, Willers J, Noack V et al (2015) Gesundheitsbezogene Lebensqualität nach Behandlung von Plattenepithelkarzinomen des Oropharynx. Laryngo-Rhino-Otol 94:509–515
Andrews G, Lango M, Cohen R et al (2011) Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience. Head Neck 33:1433–1440
Wang MB, Liu IY, Gornbein JA et al (2015) HPV-positive oropharyngeal carcinoma: a systematic review of treatment and prognosis. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 153(5):758–769
Cohen MA, Weinstein GS, O’Malley BW Jr, Feldman M, Quon H (2011) Transoral robotic surgery and human papillomavirus status: oncologic results. Head Neck 33:573–580
Chen AY, Zhu J, Fedewa S (2014) Temporal trends in oropharyngeal cancer treatment and survival: 1998–2009. Laryngoscope 124:131–138
Zenga J, Wilson M, Adkins DR et al (2015) Treatment outcomes for T4 oropharyngeal squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 141:1118–1127
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study has not received funding.
Conflict of interest
There is no conflict of interest to declare.
Research involving human participants and/or animals
No animals were involved. Human clinico-pathological data were collected retrospectively.
Informed consent
Not applicable: this was a retrospective study and data were collected in an anonymous fashion.
Additional information
Adrian Münscher and Lara Bussmann share first authorship.
Rights and permissions
About this article
Cite this article
Münscher, A., Bussmann, L., Sehner, S. et al. Survival analysis of 287 oropharyngeal squamous cell carcinoma patients in a single institution: a retrospective comparison of two consecutive time intervals with surgical and conservative treatment approaches. Eur Arch Otorhinolaryngol 274, 3211–3219 (2017). https://doi.org/10.1007/s00405-017-4615-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-017-4615-7